Impedance cardiography in the diagnosis of capillary leak syndrome caused by doxorubicin therapy in a patient with myeloma multiplex (original) (raw)

Doxorubicin cardiomyopathy in lung cancer patients

Ikram Burney

Journal of the Pakistan Medical Association

View PDFchevron_right

Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and review

Carl Freter

The American Journal of Medicine, 1986

View PDFchevron_right

Doxorubicin cardiomyopathy – case report and review of histopathologic findings (RCD code: III‐1B.5a)

Urooj Zahra

Journal of Rare Cardiovascular Diseases, 2018

View PDFchevron_right

Early Diagnosis of Chemotherapy-induced Cardiomyopathy: a Prospective Tissue Doppler Imaging Study

Csaba Nagy

Pathology & Oncology Research, 2008

View PDFchevron_right

Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: Evolution of the diastolic and systolic parameters studied by radionucide angiography

Bruno Coudert

Clinical Cardiology, 1998

View PDFchevron_right

Chemotherapy-induced cardiotoxicity

Francesca Bonura

Anti-Cancer Drugs, 2011

View PDFchevron_right

Diagnosis of Chemotherapy-Induced Cardiotoxicity

Giampiero Vizzari, Concetta Zito

Journal of Patient-Centered Research and Reviews, 2014

View PDFchevron_right

Antimyosin cardiac imaging: will it play a role in the detection of doxorubicin cardiotoxicity?

Diwakar Jain

PubMed, 1990

View PDFchevron_right

STUDY THE EFFECT OF CHEMOTHERAPY ON THE CARDIAC FUNCTION

IJAR Indexing

View PDFchevron_right

Doxorubicin-induced cardiomyopathy 17 years after chemotherapy

Clifford Yang

View PDFchevron_right

Cardiac complications and manifestations of chemotherapy for cancer

Muhammed Khawaja

Heart, 2013

View PDFchevron_right

Cardiotoxicity of doxorubicin: Causes, diagnosis, consequences and possibilities of prevention

Milana Bosanac

Hospital Pharmacology - International Multidisciplinary Journal

View PDFchevron_right

Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy

Pankaj Malhotra

Indian Journal of Medical and Paediatric Oncology, 2009

View PDFchevron_right

Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast

James Speyer

The American Journal of Medicine, 1985

View PDFchevron_right

Acute and Delayed Doxorubicin-Induced Myocardiotoxicity Associated with Elevation of Cardiac Biomarkers, Depletion of Cellular Antioxidant Enzymes, and Several Histopathological and Ultrastructural Changes

اشرف البركاتي

Life

View PDFchevron_right

Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol

Robert Boucek

Proceedings of the …, 1988

View PDFchevron_right

Physiopathology and diagnosis of cardiotoxicity in patients submitted to chemotherapy treatment

Cátia Sá

Oncology Reviews, 2019

View PDFchevron_right

8-13-2014 Diagnosis of Chemotherapy-Induced Cardiotoxicity

G V

2017

View PDFchevron_right

Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines

Jacqueline Groot-Loonen

Ultrasound in Medicine & Biology, 2000

View PDFchevron_right

Duxorubicin-induced cardiotoxicity

Mukund Joshi

View PDFchevron_right

Myocardial Dysfunction with Delayed Post-chemotherapy Enhancement Assessed in 3 Tesla Cardiac Magnetic Resonance imaging

Ibraim Pinto

ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR, 2016

View PDFchevron_right

The evaluation of doxorubicin-induced cardiotoxicity: Comparison of Doppler and tissue Doppler-derived myocardial performance index

Ahmet Bacaksiz

Cardiology Journal, 2012

View PDFchevron_right

Ultrastructural and Echocardiographic Assessment of Chronic Doxorubicin-Induced Cardiotoxicity in Rats

Alireza Mohajjel Nayebi

Archives of Razi Institute, 2020

View PDFchevron_right

The cardiotoxicity of chemotherapy: New prospects for an old problem

Antonio Murrone

Radiol, 2006

View PDFchevron_right

Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats

Kora Bruin, B. Eck-smit, Neil Steinmetz

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004

View PDFchevron_right

Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin

Denis Platel

British journal of cancer, 1999

View PDFchevron_right

A novel insight into the cardiotoxicity of antineoplastic drug doxorubicin

Iva Blazkova

International journal of molecular sciences, 2013

View PDFchevron_right

Pulmonary artery perfusion of doxorubicin with blood flow occlusion: pharmacokinetics and treatment in a metastatic sarcoma model

Bruce Ng

The Annals of Thoracic Surgery, 1995

View PDFchevron_right